Oliver Daltrop
Director Técnico/Científico/I+D en MOONLAKE IMMUNOTHERAPEUTICS .
Perfil
Oliver Daltrop is currently working as the Chief Technical Officer at Moonlake Immunotherapeutics AG and MoonLake Immunotherapeutics.
Previously, he held the position of Head-Biopharma Development Transformation at Sandoz, Inc. Mr. Daltrop has a doctorate degree from the University of Oxford and an undergraduate degree from the University of Bristol.
Cargos activos de Oliver Daltrop
| Empresas | Cargo | Inicio |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Director Técnico/Científico/I+D | 01/09/2021 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Director Técnico/Científico/I+D | 01/09/2021 |
Antiguos cargos conocidos de Oliver Daltrop.
| Empresas | Cargo | Fin |
|---|---|---|
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/08/2021 |
Formación de Oliver Daltrop.
| University of Bristol | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Empresas privadas | 2 |
|---|---|
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Oliver Daltrop
